Sn-117m has unique characteristics that make it ideal for a variety of nuclear medicine applications.The isotope emits a primary 159 keV imaging photon that is easily detectable with any SPECT camera system.The accompanying mono-energetic conversion electrons have a therapeutic effect limited to a range of ∼300 μm which also minimizes any shipping and handling issues.Together these characteristics make this theranostic isotope a prime candidate for several personalized nuclear medicine applications.This isotope can be produced in large quantities as a low specific activity (< 21 Ci/g) product in reactors via the Sn-116(n,γ) or Sn-117(n,n'γ) reactions.A carrier-free, high specific activity (up to 20,000 Ci/g) isotope can be manufactured with ∼50 MeV cyclotrons employing either Sb(p,x) or Cd-116(α,3n).Methods for extracting and purifying the Sn-117m from Sb or Cd have been developed.Sn-117m has been used to label a wide variety of targets including proteins, anti-bodies and small mols.In recent animal and human Phase I/II cardiovascular trials to detect and treat vulnerable plaque, the Sn-117m was chelated to aminobenzyl DOTA before being conjugated to annexin V.Results demonstrated the ability of this mol. to both target and image the plaques.Addnl., a remarkable therapeutic effect was observed at very low doses (∼10 cGy).In oncol., Sn-117m (chelated to DTPA) has been successfully used in over 120 humans for bone pain palliation in a Phase I/II trial.Labeling of neuroendocrine cancer targeting mols. has also been demonstrated.The isotope, in low specific activity form, has been electroplated onto stents and implanted into several animal models to demonstrate the efficacy and finite range of the conversion electrons.Rheumatol. applications include a homogeneous Sn-117m colloid that is being used to treat canine osteoarthritis (OA).Future veterinary applications include treating equine OA and human rheumatoid arthritis (RA).Labeled compounds are also being developed to image and treat RA systemically.Addnl. future applications take advantage of the limited irradiation of normal tissue in immune and inflammatory CNS conditions that could provide new therapies for this immunol. privileged system.In conclusion, the novel isotope Sn-117m is successfully finding application in several aspects of human nuclear medicine and is now also creating new opportunities in the emerging field of veterinary nuclear medicine.

100 Deals associated with Serene LLC

100 Translational Medicine associated with Serene LLC

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 27 Jun 2026

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Serene LLC

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 27 Jun 2026

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing